UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4665) 4665
Book Chapter (108) 108
Newsletter (81) 81
Newspaper Article (24) 24
Dissertation (15) 15
Publication (10) 10
Book / eBook (8) 8
Magazine Article (8) 8
Conference Proceeding (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4167) 4167
science & technology (2775) 2775
life sciences & biomedicine (2592) 2592
burkitt lymphoma - genetics (2094) 2094
biological and medical sciences (1475) 1475
burkitt lymphoma - pathology (1201) 1201
male (1124) 1124
medical sciences (1120) 1120
oncology (1076) 1076
female (1038) 1038
burkitt's lymphoma (1026) 1026
burkitt lymphoma (933) 933
hematology (854) 854
animals (850) 850
child (797) 797
hematologic and hematopoietic diseases (754) 754
translocation, genetic (736) 736
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (722) 722
cell line (721) 721
tumor cells, cultured (700) 700
herpesvirus 4, human - genetics (690) 690
adult (645) 645
lymphoma (638) 638
burkitt lymphoma - immunology (611) 611
adolescent (586) 586
base sequence (574) 574
mice (558) 558
child, preschool (540) 540
abridged index medicus (514) 514
burkitt lymphoma - metabolism (506) 506
cancer (506) 506
molecular sequence data (495) 495
middle aged (456) 456
cell line, tumor (454) 454
hemic and lymphatic diseases (447) 447
fundamental and applied biological sciences. psychology (417) 417
burkitt lymphoma - virology (405) 405
tumors (397) 397
research (391) 391
gene expression (389) 389
lymphomas (382) 382
epstein-barr virus (380) 380
biochemistry & molecular biology (370) 370
genetic aspects (354) 354
apoptosis (353) 353
burkitt lymphoma - drug therapy (349) 349
cell biology (338) 338
research article (320) 320
polymerase chain reaction (307) 307
aged (303) 303
karyotyping (302) 302
immunology (285) 285
pathology (284) 284
burkitt lymphoma - diagnosis (271) 271
virology (269) 269
gene expression regulation, neoplastic (264) 264
chromosome aberrations (262) 262
oncogenes (260) 260
herpesvirus 4, human - immunology (259) 259
transcription, genetic (259) 259
mutation (258) 258
infant (257) 257
genetics & heredity (256) 256
genes (255) 255
transfection (255) 255
viruses (251) 251
burkitt lymphoma - microbiology (242) 242
proteins (236) 236
microbiology (234) 234
health aspects (232) 232
infectious diseases (231) 231
leukemia (231) 231
prognosis (226) 226
analysis (214) 214
flow cytometry (213) 213
genes, myc (213) 213
b-lymphocytes - immunology (206) 206
immunophenotyping (200) 200
burkitt lymphoma - etiology (199) 199
herpesvirus 4, human - isolation & purification (198) 198
herpesvirus 4, human - physiology (198) 198
lymphocytes b (194) 194
amino acid sequence (193) 193
b-lymphocytes - metabolism (192) 192
dna-binding proteins - genetics (191) 191
molecular and cellular biology (188) 188
rna, messenger - genetics (188) 188
chemotherapy (185) 185
in situ hybridization, fluorescence (184) 184
proto-oncogene proteins c-myc - genetics (181) 181
science & technology - other topics (175) 175
immunoglobulin heavy chains - genetics (174) 174
multidisciplinary sciences (173) 173
lymphoma, b-cell - genetics (172) 172
precursor cell lymphoblastic leukemia-lymphoma - genetics (172) 172
gene rearrangement (170) 170
genes, viral (168) 168
nucleic acid hybridization (167) 167
immune system diseases (161) 161
viral diseases (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4763) 4763
French (53) 53
Chinese (52) 52
Japanese (43) 43
German (23) 23
Russian (15) 15
Spanish (15) 15
Polish (10) 10
Portuguese (7) 7
Italian (6) 6
Hungarian (3) 3
Hebrew (2) 2
Croatian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of molecular sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2475
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Lymphoma | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites | Index Medicus | diffuse large B-cell lymphoma (DLBCL) | chronic lymphocytic leukemia (CLL) | burkitt lymphoma (BL) | gene regulation | circular RNA | acute lymphoblastic leukemia (ALL) | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM)
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 12/2012, Volume 44, Issue 12, pp. 1321 - 1325
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Infectious diseases | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus | high-grade B-cell lymphoma | diffuse large B-cell lymphoma | cytogenetics
Journal Article
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
Journal Article